NEVVI Medicare utilization intelligence

← back

Provider profile

CLOVEN, NOELLE M.D.

Gynecological Oncology · NPI 1477518686 · FORT WORTH, TX

1
Groups
46
Codes · 2024
44,081
Disclosed services

CLOVEN, NOELLE is a Gynecological Oncology in FORT WORTH, TX, a member of 1 medical group, who billed 46 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

44,081
disclosed services
46
codes billed to Medicare Part B
Prior year · CY2023 35,722 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J1453 Injection, fosaprepitant, 1 mg premiumpremium premiumpremium
J9025 Injection, azacitidine, 1 mg premiumpremium premiumpremium
J9267 Injection, paclitaxel, 1 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
J1626 Injection, granisetron hydrochloride, 100 mcg premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
80053 Blood test, comprehensive group of blood chemicals premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125 premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J9045 Injection, carboplatin, 50 mg premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
J3489 Injection, zoledronic acid, 1 mg premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
J3490 Unclassified drugs premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
85007 Microscopic examination for white blood cells with manual cell count premiumpremium premiumpremium
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test premiumpremium premiumpremium
96377 Application of on-body injector for under skin injection premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
84443 Blood test, thyroid stimulating hormone (tsh) premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
81001 Manual urinalysis test with examination using microscope, automated premiumpremium premiumpremium
96361 Infusion into a vein for hydration, each additional hour premiumpremium premiumpremium
83540 Iron level premiumpremium premiumpremium
83550 Iron binding capacity premiumpremium premiumpremium
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion premiumpremium premiumpremium
82728 Ferritin (blood protein) level premiumpremium premiumpremium
78815 Nuclear medicine study from skull base to mid-thigh with ct scan premiumpremium premiumpremium
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries premiumpremium premiumpremium
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less premiumpremium premiumpremium
80048 Blood test, basic group of blood chemicals (calcium, total) premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.